Physician Assistant · Tampa, FL
NPI
1699139998
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13330 Usf Laurel Dr
Tampa, FL, 33612
Phone (813) 821-8038
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
358 services
Medicare patients, 2024
125
Average age 61
Drug cost, 2024
$4.9M
3,085 prescriptions
Company payments, 2025
$4,038
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel L Duke was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 162 times for 108 patients. In total Rachel L Duke billed 358 services in 5 codes, and Medicare paid $18K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 162 | 108 | $10.62 | $1,721 |
| 99214 Office E&M - Established | Office | 136 | 97 | $72.86 | $9,908 |
| 99215 Office E&M - Established | Office | 48 | 40 | $110.90 | $5,323 |
By year: 2023 $2,019 for 31 services; 2024 $18K for 358 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel L Duke prescribed most often to Medicare patients was Gabapentin, with 215 prescriptions and refills. In total Rachel L Duke wrote 3,085 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 215 | 400 | 69 | $4,483 |
| Baclofen Generic | 213 | 468 | 74 | $6,507 |
| Teriflunomide Generic | 162 | 188 | 24 | $111K |
| Kesimpta Pen Ofatumumab | 159 | 172 | 27 | $1.6M |
| Duloxetine Hcl Generic | 116 | 221 | 34 | $2,222 |
| Tizanidine Hcl Generic | 112 | 224 | 35 | $2,113 |
| Dalfampridine Er Dalfampridine | 106 | 194 | 37 | $53K |
| Pregabalin Generic | 103 | 139 | 26 | $2,183 |
| Clonazepam Generic | 91 | 105 | 18 | $948 |
| Dimethyl Fumarate Generic | 89 | 111 | 15 | $40K |
| Diazepam Generic | 88 | 89 | 25 | $365 |
| Tramadol Hcl Generic | 88 | 92 | 19 | $858 |
| Alprazolam Generic | 66 | 70 | 23 | $271 |
| Zolpidem Tartrate Generic | 64 | 94 | 15 | $539 |
| Amantadine Amantadine Hcl | 60 | 134 | 22 | $2,200 |
Brand drugs: 577 claims; generic drugs: 2,508 claims; opioid claims: 90.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel L Duke $4,038 ($4,038 in general payments such as food, travel and fees) from 10 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,879.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 13 | $1,879 |
| TG Therapeutics, Inc. TGTX | 7 | $1,429 |
| Biogen, Inc. BIIB | 4 | $314 |
| Abbvie Inc. ABBV | 2 | $131 |
| EMD Serono, Inc. MRK.DE | 3 | $93.63 |
| Celgene Corporation BMY | 1 | $72.24 |
| Genzyme Corporation SNY | 1 | $40.58 |
| Amgen Inc. AMGN | 1 | $33.86 |
| Genentech, Inc. ROG.SW | 1 | $23.66 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $20.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.